Innovative MedTech Enters Material Definitive Agreement

TL;DR

**IMTH just signed a big new deal, could be a game-changer!**

AI Summary

Innovative MedTech, Inc. (IMTH) entered into a material definitive agreement on December 29, 2023, as reported in this 8-K filing. This filing indicates a significant new contract or partnership, which could impact the company's future revenue and strategic direction. For investors, this matters because such agreements often signal growth opportunities or changes in business operations that could affect the stock's valuation.

Why It Matters

This filing signals a new, important business deal for Innovative MedTech, which could lead to new revenue streams or strategic shifts, potentially impacting the company's financial performance and stock price.

Risk Assessment

Risk Level: medium — The filing indicates a material agreement but lacks specific details, making it difficult to assess the full impact and associated risks or benefits.

Analyst Insight

Investors should monitor for subsequent filings or press releases from Innovative MedTech, Inc. that provide specific details about the 'Material Definitive Agreement' to understand its potential impact on the company's financials and strategic direction before making investment decisions.

Key Players & Entities

• Innovative MedTech, Inc. (company) — the registrant filing the 8-K
• December 29, 2023 (date) — date of the earliest event reported
• Delaware (company) — state of incorporation for Innovative MedTech, Inc.
• 000-24189 (company) — Commission File Number for Innovative MedTech, Inc.
• 33-1130446 (company) — IRS Employer Identification No. for Innovative MedTech, Inc.

Forward-Looking Statements

• Innovative MedTech, Inc. will file an amendment or a subsequent 8-K providing more details about the material definitive agreement. (Innovative MedTech, Inc.) — medium confidence, target: Q1 2024

FAQ

Filing Documents

• imth_8k.htm (8-K) — 21KB
• imth_ex101.htm (EX-10.1) — 92KB
• imth_ex101img5.jpg (GRAPHIC) — 4KB
• imth_ex101img4.jpg (GRAPHIC) — 2KB
• imth_ex101img3.jpg (GRAPHIC) — 2KB
• imth_ex101img2.jpg (GRAPHIC) — 2KB
• imth_ex101img1.jpg (GRAPHIC) — 2KB
• 0001477932-24-000051.txt ( ) — 263KB
• imth-20231229.xsd (EX-101.SCH) — 6KB
• imth-20231229_lab.xml (EX-101.LAB) — 13KB
• imth-20231229_cal.xml (EX-101.CAL) — 1KB
• imth-20231229_pre.xml (EX-101.PRE) — 8KB
• imth-20231229_def.xml (EX-101.DEF) — 2KB
• imth_8k_htm.xml (XML) — 3KB

01 Entry into a Material Definitive Agreement

Item 1.01 Entry into a Material Definitive Agreement. On or about December 29, 2023, Innovative MedTech, Inc. (" Innovative " or the " Company ") entered into a Distribution License Agreement (the " Distribution License Agreement ") with Radical Clean Solutions Ltd., a Nevada corporation (" RCS ") which has developed several air cleaning devices that send out atmospheric hydroxyls to attach to either pathogens or VOCs, and then neutralize them, whether in the air or on surfaces, and which seek to mimic natural outdoor atmospheric hydroxyl. The Distribution License Agreement gives the Company the right to distribute the RCS products in the following markets within the USA and Canada: (a) military, FEMA, and medical facilities (emergency room, urgent care, hospital, and outpatient clinic facilities), (b) adult day and nursing homes, (c) municipal pet shelters, zoos, equestrian and other veterinary facilities, (d) transportation hubs (via TSA Policy ordinances), and (e) educational facilities, and provided that the Company meets minimum sales requirements with respect to those RCS products, the Company's distribution rights shall be exclusive in those markets. The foregoing description of the Distribution License Agreement does not purport to be complete and is qualified in its entirety by reference to the Distribution License Agreement, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated in this Item 1.01 by reference.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 10.1 Distribution License Agreement, by and between Innovative MedTech, Inc., and Radical Clean Solutions Ltd., dated December 29, 2023. 104 Cover Page Interactive Data File (embedded within the Inline XBRL Document) 2

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Innovative MedTech, Inc. Date: January 5, 2024 By: /s/ Michael Jordan Friedman Michael Jordan Friedman President 3

View Full Filing

View this 8-K filing on SEC EDGAR